BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9680350)

  • 1. Intermittent, repetitive corticosteroid-induced upregulation of platelet levels after adenovirus-mediated transfer to the liver of a chimeric glucocorticoid-responsive promoter controlling the thrombopoietin cDNA.
    Narumi K; Suzuki M; Song W; Moore MA; Crystal RG
    Blood; 1998 Aug; 92(3):822-33. PubMed ID: 9680350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous control of cardiac gene therapy: evidence of regulated myocardial transgene expression after adenovirus and adeno-associated virus transfer of expression cassettes containing corticosteroid response element promoters.
    Lee LY; Zhou X; Polce DR; El-Sawy T; Patel SR; Thakker GD; Narumi K; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):26-4, discussion 34-5. PubMed ID: 10384181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarity of strain- and route-dependent murine responses to an adenovirus vector using the homologous thrombopoietin cDNA as the reporter genes.
    Suzuki M; Singh R; Moore MA; Song WR; Crystal RG
    Hum Gene Ther; 1998 May; 9(8):1223-31. PubMed ID: 9625262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression.
    Ohwada A; Rafii S; Moore MA; Crystal RG
    Blood; 1996 Aug; 88(3):778-84. PubMed ID: 8704230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells.
    Mader S; White JH
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5603-7. PubMed ID: 8390672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences.
    Vacca A; Martinotti S; Screpanti I; Maroder M; Felli MP; Farina AR; Gismondi A; Santoni A; Frati L; Gulino A
    J Biol Chem; 1990 May; 265(14):8075-80. PubMed ID: 2159467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
    Song W; Kong HL; Traktman P; Crystal RG
    Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of platelet production by hTPO cDNA injection.
    Zhao JZ; Liu L; Li Y
    Haematologica; 1997; 82(3):383. PubMed ID: 9234599
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis.
    Frey BM; Rafii S; Teterson M; Eaton D; Crystal RG; Moore MA
    J Immunol; 1998 Jan; 160(2):691-9. PubMed ID: 9551904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: is direct DNA binding necessary?
    Ray A; LaForge KS; Sehgal PB
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7086-90. PubMed ID: 1871124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of blood platelet levels by intratracheal administration of an adenovirus vector encoding human thrombopoietin cDNA.
    Cannizzo SJ; Frey BM; Raffi S; Moore MA; Eaton D; Suzuki M; Singh R; Mack CA; Crystal RG
    Nat Biotechnol; 1997 Jun; 15(6):570-3. PubMed ID: 9181581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of glucocorticoid receptor-mediated gene expression by heat and chemical shock.
    Sanchez ER; Hu JL; Zhong S; Shen P; Greene MJ; Housley PR
    Mol Endocrinol; 1994 Apr; 8(4):408-21. PubMed ID: 8052262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus vector-mediated perforin expression driven by a glucocorticoid-inducible promoter inhibits tumor growth in vivo.
    Narumi K; Kojima A; Crystal RG
    Am J Respir Cell Mol Biol; 1998 Dec; 19(6):936-41. PubMed ID: 9843928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells.
    Kumar-Singh R; Chamberlain JS
    Hum Mol Genet; 1996 Jul; 5(7):913-21. PubMed ID: 8817325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological expression in rat hepatocytes of a gene transferred by an adenovirus vector enabled by a chimeric promoter containing multiple cyclic adenosine monophosphate response elements.
    Suzuki M; Singh RN; Crystal RG
    Hepatology; 1998 Jan; 27(1):160-5. PubMed ID: 9425932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-inducible retrovector for regulated transgene expression in genetically engineered bone marrow stromal cells.
    Jaalouk DE; Eliopoulos N; Couture C; Mader S; Galipeau J
    Hum Gene Ther; 2000 Sep; 11(13):1837-49. PubMed ID: 10986557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
    Chatterjee VK; Madison LD; Mayo S; Jameson JL
    Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatable promoters for use in gene therapy applications: modification of the 5'-flanking region of the CFTR gene with multiple cAMP response elements to support basal, low-level gene expression that can be upregulated by exogenous agents that raise intracellular levels of cAMP.
    Suzuki M; Singh RN; Crystal RG
    Hum Gene Ther; 1996 Oct; 7(15):1883-93. PubMed ID: 8894680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors.
    Chuah MK; Schiedner G; Thorrez L; Brown B; Johnston M; Gillijns V; Hertel S; Van Rooijen N; Lillicrap D; Collen D; VandenDriessche T; Kochanek S
    Blood; 2003 Mar; 101(5):1734-43. PubMed ID: 12406898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.